Trump fetal tissue ethics board urges rejection of nearly all research proposals
By Amy Goldstein,
The Washington Post
| 08. 18. 2020
A new advisory board, created to review the ethics of proposed fetal tissue research grants, is urging the Trump administration to block government funding for nearly all of the applications — essentially seeking to ban support for most such scientific work.
The recommendation that the National Institutes of Health withhold funds from all but one of a slate of 14 research proposals means that Health and Human Services Secretary Alex Azar, who has the final say, would need to buck the will of a board he convened — and of social conservatives crucial to President Trump’s political base — for the projects to get federal support.
The board sent its advice in a report to HHS on Tuesday, less than three weeks after the announcement of its members, two-thirds of whom are outspoken opponents of abortion, fetal tissue research or both. The group has operated in secrecy, with even its own members unaware of who else was in it until the end of July, when it held a single, day-long virtual meeting, most of it closed to the public...
Related Articles
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...